The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Is there an advantage to adding inferior vena cava filter (IVCF) placement to anticoagulation with fondaparinux in patients with cancer and venous thromboemboli (VTE): Results of the Cancer and Thrombosis (CAT) prospective randomized clinical trial (RCT).
M. F. Barginear
No relevant relationships to disclose
R. J. Gralla
No relevant relationships to disclose
M. Akerman
No relevant relationships to disclose
M. Lesser
No relevant relationships to disclose
T. P. Bradley
No relevant relationships to disclose
I. Shapira
No relevant relationships to disclose
N. J. Nier-Shoulson
No relevant relationships to disclose
C. R. Greben
No relevant relationships to disclose
D. R. Budman
No relevant relationships to disclose